{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T09:32:57Z","timestamp":1786699977895,"version":"build-2736575974"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:p>The growing burden of male hypogonadism has raised concerns regarding the potential impact of modern lifestyles and environmental exposures on male reproductive health. Testosterone replacement therapy (TRT) is widely used for the treatment of male hypogonadism. However, prolonged TRT may suppress the hypothalamic-pituitary-testicular (HPT) axis, resulting in reduced gonadotropin production, decreased intratesticular testosterone levels, impaired spermatogenesis, testicular atrophy, and compromised fertility. Current management strategies, including human chorionic gonadotropin (hCG), follicle-stimulating hormone (FSH), and selective estrogen receptor modulators (SERMs), can support recovery in some patients, but their effectiveness remains variable. This narrative review examines the emerging role of peptide and neuroendocrine strategies in TRT-induced reproductive suppression and functional male hypogonadism. A structured literature search was conducted to identify experimental, translational, and clinical studies investigating reproductive peptides and related neuroendocrine pathways. Particular attention was given to kisspeptin-based therapies, gonadotropin-releasing hormone (GnRH)-related approaches, neurokinin signaling pathways, and other developing interventions with potential relevance to male reproductive health. Current evidence suggests that peptide-based therapies may support endogenous hormonal signaling through targeted activation of the HPT axis. However, direct evidence demonstrating restoration of spermatogenesis or fertility following TRT-induced suppression remains limited, and important questions regarding long-term efficacy, safety, treatment protocols, and patient selection remain unresolved. Emerging peptide therapeutics represent a growing area of interest in reproductive endocrinology and may expand future treatment options for selected patients. Nevertheless, further well-designed clinical studies are required to establish their long-term efficacy, safety, and role in restoring reproductive function following TRT-induced suppression.<\/jats:p>","DOI":"10.3389\/frph.2026.1914709","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:53:05Z","timestamp":1786697585000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging peptide and neuroendocrine strategies for TRT-induced reproductive suppression and functional male hypogonadism: a narrative review"],"prefix":"10.3389","volume":"8","author":[{"given":"Ana-Maria","family":"Cretu","sequence":"first","affiliation":[{"name":"Origyn Fertility Center","place":["Ia\u0219i, Rom\u00e2nia"]},{"name":"Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy Iasi","place":["Ia\u0219i, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Adel Mansour","family":"Kamar","sequence":"additional","affiliation":[{"name":"Department Biology, Faculty of Biology, Doctoral School, Alexandru Ioan Cuza University","place":["Ia\u0219i, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alin","family":"Ciobica","sequence":"additional","affiliation":[{"name":"Origyn Fertility Center","place":["Ia\u0219i, Rom\u00e2nia"]},{"name":"Department Biology, Faculty of Biology, Alexandru Ioan Cuza University (UAIC)","place":["Ia\u0219i, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos","family":"Puia","sequence":"additional","affiliation":[{"name":"Origyn Fertility Center","place":["Ia\u0219i, Rom\u00e2nia"]},{"name":"Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy Iasi","place":["Ia\u0219i, Romania"]},{"name":"Department of Urology, \u201cDr. C.I. Parhon\u201d Clinical Hospital","place":["Ia\u0219i, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Doroftei","sequence":"additional","affiliation":[{"name":"Origyn Fertility Center","place":["Ia\u0219i, Rom\u00e2nia"]},{"name":"Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy Iasi","place":["Ia\u0219i, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Doroftei","sequence":"additional","affiliation":[{"name":"Origyn Fertility Center","place":["Ia\u0219i, Rom\u00e2nia"]},{"name":"Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy Iasi","place":["Ia\u0219i, Romania"]},{"name":"Spitalul Clinic de Obstetric\u0103 \u0219i Ginecologie \u201cCuza Vod\u0103\u201d","place":["Ia\u0219i, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an endocrine society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.eururo.2025.04.010","article-title":"European association of urology guidelines on male sexual and reproductive health: 2025 update on male hypogonadism, erectile dysfunction, premature ejaculation, and Peyronie's disease","volume":"88","author":"Salonia","year":"2025","journal-title":"Eur Urol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.maturitas.2018.04.004","article-title":"Testosterone and sexual function in men","volume":"112","author":"Rastrelli","year":"2018","journal-title":"Maturitas"},{"key":"B4","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/andr.12770","article-title":"European Academy of andrology guidelines on investigation, treatment and monitoring of functional hypogonadism in males","volume":"8","author":"Corona","year":"2020","journal-title":"Andrology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and management of testosterone deficiency: AUA guideline","volume":"200","author":"Mulhall","year":"2018","journal-title":"J Urol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1573526","DOI":"10.3389\/fendo.2025.1573526","article-title":"The impact, mechanisms and prevention strategies of environmental endocrine disruptors on male reproductive health","volume":"16","author":"Han","year":"2025","journal-title":"Front Endocrinol (Lausanne"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1232646","DOI":"10.3389\/fpubh.2023.1232646","article-title":"Endocrine disrupting chemicals and male fertility: from physiopathological to molecular effects","volume":"11","author":"Lahimer","year":"2023","journal-title":"Front Public Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1117155","DOI":"10.3389\/fcell.2023.1117155","article-title":"Human sperm proteome reveals the effect of environmental borne seminal polyaromatic hydrocarbons exposome in etiology of idiopathic male factor infertility","volume":"11","author":"Nayak","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4103\/1008-682X.173938","article-title":"Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use","volume":"18","author":"McBride","year":"2016","journal-title":"Asian J Androl"},{"key":"B10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3978\/j.issn.2223-4683.2013.06.01","article-title":"Exogenous testosterone: a preventable cause of male infertility","volume":"2","author":"Crosnoe","year":"2013","journal-title":"Transl Androl Urol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5534\/wjmh.180036","article-title":"Testosterone is a contraceptive and should not be used in men who desire fertility","volume":"37","author":"Patel","year":"2019","journal-title":"World J Mens Health"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(06)68614-5","article-title":"Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis","volume":"367","author":"Liu","year":"2006","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1210\/jc.2004-0802","article-title":"Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression","volume":"90","author":"Coviello","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.5534\/wjmh.190002","article-title":"Management of anabolic steroid-induced infertility: novel strategies for fertility maintenance and recovery","volume":"38","author":"Tatem","year":"2020","journal-title":"World J Mens Health"},{"key":"B15","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.juro.2012.09.043","article-title":"Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy","volume":"189","author":"Hsieh","year":"2013","journal-title":"J Urol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/jsm.12890","article-title":"The use of HCG-based combination therapy for recovery of spermatogenesis after testosterone use","volume":"12","author":"Wenker","year":"2015","journal-title":"J Sex Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.fertnstert.2013.09.003","article-title":"Testosterone use in the male infertility population: prescribing patterns and effects on semen and hormonal parameters","volume":"101","author":"Samplaski","year":"2014","journal-title":"Fertil Steril"},{"key":"B18","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.fertnstert.2012.10.052","article-title":"The treatment of hypogonadism in men of reproductive age","volume":"99","author":"Kim","year":"2013","journal-title":"Fertil Steril"},{"key":"B19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1464-410X.2011.10702.x","article-title":"Outcomes of clomiphene citrate treatment in young hypogonadal men","volume":"110","author":"Katz","year":"2012","journal-title":"BJU Int"},{"key":"B20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3909\/riu0711","article-title":"The role of estrogen modulators in male hypogonadism and infertility","volume":"18","author":"Rambhatla","year":"2016","journal-title":"Rev Urol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/JU.0000000000001521","article-title":"Diagnosis and treatment of infertility in men: aUA\/ASRM guideline part I","volume":"205","author":"Schlegel","year":"2021","journal-title":"J Urol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/JU.0000000000001520","article-title":"Diagnosis and treatment of infertility in men: AUA\/ASRM guideline part II","volume":"205","author":"Schlegel","year":"2021","journal-title":"J Urol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1210\/endrev\/bnad023","article-title":"The emerging therapeutic potential of kisspeptin and neurokinin B","volume":"45","author":"Patel","year":"2024","journal-title":"Endocr Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1152\/physrev.00015.2024","article-title":"Kisspeptin and neurokinin B: roles in reproductive health","volume":"105","author":"Koysombat","year":"2025","journal-title":"Physiol Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"bqad194","DOI":"10.1210\/endocr\/bqad194","article-title":"KNDy neurons of the hypothalamus and their role in GnRH pulse generation: an update","volume":"165","author":"Moore","year":"2024","journal-title":"Endocrinology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/humupd\/dmu009","article-title":"The kisspeptin-GnRH pathway in human reproductive health and disease","volume":"20","author":"Skorupskaite","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B27","doi-asserted-by":"publisher","first-page":"724632","DOI":"10.3389\/fendo.2021.724632","article-title":"Role of KNDy neurons expressing kisspeptin, neurokinin B and dynorphin A as a GnRH pulse generator","volume":"12","author":"Ohkura","year":"2021","journal-title":"Front Endocrinol (Lausanne"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1210\/jc.2005-1468","article-title":"Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males","volume":"90","author":"Dhillo","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1056\/NEJMoa035322","article-title":"The GPR54 gene as a regulator of puberty","volume":"349","author":"Seminara","year":"2003","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"E1228","DOI":"10.1210\/JC.2011-0089","article-title":"Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men","volume":"96","author":"George","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000488452","article-title":"Hypothalamic response to kisspeptin-54 and pituitary response to gonadotropin-releasing hormone are preserved in healthy older men","volume":"106","author":"Abbara","year":"2018","journal-title":"Neuroendocrinology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e2254313","DOI":"10.1001\/jamanetworkopen.2022.54313","article-title":"Effects of kisspeptin on sexual brain processing and penile tumescence in men with hypoactive sexual desire disorder: a randomized clinical trial","volume":"6","author":"Mills","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/cen.12103","article-title":"Exploring the pathophysiology of hypogonadism in men with type 2 diabetes: kisspeptin-10 stimulates serum testosterone and LH secretion in men with type 2 diabetes and mild biochemical hypogonadism","volume":"79","author":"George","year":"2013","journal-title":"Clin Endocrinol (Oxf"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1093\/humrep\/dev143","article-title":"Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men","volume":"30","author":"Jayasena","year":"2015","journal-title":"Hum Reprod"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1210\/clinem\/dgaf128","article-title":"Kisspeptin administration stimulates reproductive hormones but does not affect anxiety in humans","volume":"110","author":"Mills","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/medicina60010050","article-title":"Impact of GLP-1 agonists on male reproductive health: a narrative review","volume":"60","author":"Varnum","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1496416","DOI":"10.3389\/fphys.2024.1496416","article-title":"Potential impact of GLP-1 receptor agonists on male fertility: a fable of caution","volume":"15","author":"Du Plessis","year":"2024","journal-title":"Front Physiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/endrev\/bnab001","article-title":"Androgen misuse and abuse","volume":"42","author":"Handelsman","year":"2021","journal-title":"Endocr Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/14740338.2018.1424831","article-title":"The safety of available treatments of male hypogonadism in organic and functional hypogonadism","volume":"17","author":"Corona","year":"2018","journal-title":"Expert Opin Drug Saf"}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2026.1914709\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:53:08Z","timestamp":1786697588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2026.1914709\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":39,"alternative-id":["10.3389\/frph.2026.1914709"],"URL":"https:\/\/doi.org\/10.3389\/frph.2026.1914709","relation":{},"ISSN":["2673-3153"],"issn-type":[{"value":"2673-3153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"article-number":"1914709"}}